Skip to content
Riskpilot
← Back to search
Sign in
Get full access
NANOVISIO OY
OY
Active
Y-tunnus 1015054-7
Ajurintie 2, 67100
Kokkola
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 1995
— employees
www.nanovisio.fi
Watchlist
Share
Finland
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
NANOVISIO OY
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
0M
3M
6M
9M
12M
0M
2021
0M
2022
0M
2023
10M
2024
0M
2025
EBITDA
EUR millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
EUR thousands
Item
2021
2022
2023
2024
2025
Revenue
190
23
32
10 484
33
Staff expenses
−30
−0
−21
−4 478
−19
EBITDA
118
12
−30
—
−45
Depreciation & amort.
—
—
−0
−0
−0
EBIT
118
12
−30
148
−45
Net financials
−0
−0
−0
—
0
Profit before tax
118
12
−31
—
−45
Tax
22
1
1
1
−0
Net profit
97
11
−32
1
−45
Balance sheet
EUR thousands
Item
2021
2022
2023
2024
2025
Total assets
243
215
172
169
110
Equity
221
215
16 652
154
97
Long-term debt
—
—
0
0
0
Short-term debt
22
0
5
15
13
Total debt
22
0
5
15
13
Financial ratios
5-year trend
EBITDA margin
-137.3%
This company
15.8%
Market median
-969% vs market
2021
2025
Equity ratio
87.9%
This company
38.2%
Market median
+130% vs market
2021
2025
Return on equity
-46.2%
This company
18.4%
Market median
-351% vs market
2021
2025
Net profit margin
-136.7%
This company
8.1%
Market median
-1788% vs market
2021
2025
Asset turnover
0.30×
This company
1.12×
Market median
-73% vs market
2021
2025
Debt / equity
0.14×
This company
0.62×
Market median
+77% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via PRH / YTJ · Period 2024-08-01 – 2025-07-31
View
PDF
Annual report 2024
Filed via PRH / YTJ · Period 2023-08-01 – 2024-07-31
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2022-08-01 – 2023-07-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2021-08-01 – 2022-07-31
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2020-08-01 – 2021-07-31
View
PDF
More on NANOVISIO OY
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network